Enanta Pharmaceuticals
ENTA
#7451
Rank
NZ$0.72 B
Marketcap
NZ$25.27
Share price
3.62%
Change (1 day)
85.59%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$0.38 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.38 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30NZ$0.39 B-4.64%
2023-09-30NZ$0.40 B326.94%
2022-09-30NZ$95.93 M68.09%
2021-09-30NZ$57.07 M23.72%
2020-09-30NZ$46.13 M5.68%
2019-09-30NZ$43.65 M40.71%
2018-09-30NZ$31.02 M-10.62%
2017-09-30NZ$34.7 M122.19%
2016-09-30NZ$15.62 M1.26%
2015-09-30NZ$15.42 M78.17%
2014-09-30NZ$8.65 M10.41%
2013-09-30NZ$7.84 M-21.15%
2012-09-30NZ$9.94 M84.28%
2011-09-30NZ$5.39 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AbbVie
ABBV
NZ$236.27 B 61,454.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.53 B 51,101.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$13.05 B 3,301.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 34,911.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.51 B 35,205.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.25 B 28,101.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland